Delayed Gadolinium-enhanced Magnetic Resonance (MR) Imaging of Cartilage - A Pilot Study to Measure the Effect of Adalimumab Plus MTX Versus Placebo Plus MTX on Cartilage in Early RA Patients
Phase of Trial: Phase III
Latest Information Update: 30 Nov 2017
Price : $35 *
At a glance
- Drugs Adalimumab (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 17 Oct 2017 Status changed from recruiting to discontinued.
- 04 Apr 2017 Planned End Date changed from 1 Jun 2016 to 1 Jun 2018.